Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
The company already has the world’s largest capacity for ibuprofen and is now looking at expansion in new molecules as the idea is to actually de-risk the business
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
Covaxin is not approved in the USA for any age group
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Serina has over 17 years of experience in the biopharmaceutical industry
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
Under the terms of the agreement, the upfront payment from Alexion to Neurimmune is US $ 30m
Subscribe To Our Newsletter & Stay Updated
